Baricitinib vs Osimertinib

Baricitinib vs Osimertinib: Overview

This comparison examines the pharmacological differences between Baricitinib and Osimertinib.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Osimertinib — C28H33N7O2.

Molecular Weight: Baricitinib — 371.4170 g/mol; Osimertinib — 499.6050 g/mol.

Type: Baricitinib — Small molecule; Osimertinib — Small molecule.